No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: No data, No communication,,no interest!!

"Even the Oct/23 AGM presentation has been removed."

Hello, narmac. I trust all is well after the Bioasis debacle.

Annual Meeting of the Shareholders of Zenith Capital Corp.

Zenith Capital Corp. held its Annual Meeting of the Shareholders on Thursday, October 26, 2023.

 

A copy of the management present may be found HERE

 

Happy New Year to all.....All the very best for a prosperous 2024

 

Koo

 

 

 

Share
New Message
Please login to post a reply